Page last updated: 2024-08-25

rosiglitazone and Acute Brain Injuries

rosiglitazone has been researched along with Acute Brain Injuries in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (23.08)29.6817
2010's7 (53.85)24.3611
2020's3 (23.08)2.80

Authors

AuthorsStudies
Jiao, Y; Ren, S; Wang, L; Wu, G1
Alqahtani, F; Cruz-Topete, D; Cucullo, L; Dhaibar, H; Sivandzade, F1
Dang, B; Gong, Y; Ji, J; Li, J; Qian, M; Shen, J; Tang, J; Wu, M1
Hang, H; Liu, C; Mu, Q; Wang, L; Wu, G1
Sullivan, PG; Yonutas, HM1
Neuhaus, W; Thal, SC1
Jiao, Y; Wang, F; Wang, L; Wu, G; Wu, J; Zhang, Y1
Chen, G; Chen, J; Gu, C; Li, J; Wang, Y; Wu, C; Yan, F1
Yao, J; Zhang, X; Zheng, K1
Culver, S; Dixon, CE; Graham, SH; Liu, H; Ma, X; Rose, ME1
Brooks, N; Lang, BT; Park, SW; Vemuganti, R; Yi, JH1
Deng, Y; Huang, Y; Li, R; Li, Y; Sun, H; Yang, J; Yu, X; Zhao, G1
Hyong, A; Jadhav, V; Lee, S; Rowe, J; Tang, J; Tong, W; Zhang, JH1

Reviews

2 review(s) available for rosiglitazone and Acute Brain Injuries

ArticleYear
Targeting PPAR isoforms following CNS injury.
    Current drug targets, 2013, Volume: 14, Issue:7

    Topics: Animals; Brain Injuries; Drug Design; Humans; Mitochondrial Proteins; Molecular Targeted Therapy; Neuroprotective Agents; Peroxisome Proliferator-Activated Receptors; Pioglitazone; Protein Isoforms; Rosiglitazone; Spinal Cord Injuries; Thiazolidinediones

2013
The blood-brain barrier as a target in traumatic brain injury treatment.
    Archives of medical research, 2014, Volume: 45, Issue:8

    Topics: Blood-Brain Barrier; Brain Edema; Brain Injuries; Cell Hypoxia; Humans; Hypoglycemic Agents; Inflammation; Myosin-Light-Chain Kinase; Neurodegenerative Diseases; Neuroprotective Agents; Peroxisome Proliferator-Activated Receptors; Pioglitazone; Receptors, Glucocorticoid; Rosiglitazone; Thiazolidinediones

2014

Other Studies

11 other study(ies) available for rosiglitazone and Acute Brain Injuries

ArticleYear
PPARĪ³/RAD21 alleviates peripheral secondary brain injury in rat cerebral hemorrhage model through promoting M2 polarization of microglial cells.
    International immunopharmacology, 2023, Volume: 114

    Topics: Animals; Brain Injuries; Brain Neoplasms; Cerebral Hemorrhage; Interleukin-10; Microglia; PPAR gamma; Rats; Rosiglitazone; Thrombin; Tumor Necrosis Factor-alpha

2023
Antidiabetic Drugs Can Reduce the Harmful Impact of Chronic Smoking on Post-Traumatic Brain Injuries.
    International journal of molecular sciences, 2023, Mar-25, Volume: 24, Issue:7

    Topics: Animals; Blood-Brain Barrier; Brain Injuries; Brain Injuries, Traumatic; Hypoglycemic Agents; Male; Metformin; Mice; Mice, Inbred C57BL; Rosiglitazone; Tobacco Smoking

2023
Rosiglitazone inhibits acyl-CoA synthetase long-chain family number 4 and improves secondary brain injury in a rat model of surgical brain injury.
    Clinical and experimental pharmacology & physiology, 2023, Volume: 50, Issue:12

    Topics: Animals; Brain; Brain Injuries; Brain Neoplasms; Iron; Ligases; Male; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Rosiglitazone; Transferrins

2023
Rosiglitazone pretreatment influences thrombin-induced phagocytosis by rat microglia via activating PPARĪ³ and CD36.
    Neuroscience letters, 2017, 06-09, Volume: 651

    Topics: Animals; Brain Injuries; CD36 Antigens; Cerebral Hemorrhage; Microglia; Neuroprotective Agents; Phagocytosis; PPAR gamma; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Thrombin

2017
Rosiglitazone infusion therapy following minimally invasive surgery for intracerebral hemorrhage evacuation decreases matrix metalloproteinase-9 and blood-brain barrier disruption in rabbits.
    BMC neurology, 2015, Mar-17, Volume: 15

    Topics: Animals; Blood-Brain Barrier; Brain; Brain Injuries; Cerebral Hemorrhage; Disease Models, Animal; Hematoma; Hypoglycemic Agents; Infusions, Intraventricular; Male; Matrix Metalloproteinase 9; Minimally Invasive Surgical Procedures; Permeability; PPAR gamma; Rabbits; Random Allocation; Rosiglitazone; Thiazolidinediones

2015
Rosiglitazone attenuates early brain injury after experimental subarachnoid hemorrhage in rats.
    Brain research, 2015, Oct-22, Volume: 1624

    Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries; Caspase 3; Cyclin D1; Disease Models, Animal; In Situ Nick-End Labeling; Male; Matrix Metalloproteinase 9; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Rosiglitazone; Subarachnoid Hemorrhage; Thiazolidinediones

2015
Rosiglitazone exerts neuroprotective effects via the suppression of neuronal autophagy and apoptosis in the cortex following traumatic brain injury.
    Molecular medicine reports, 2015, Volume: 12, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Brain; Brain Injuries; Caspase 3; Disease Models, Animal; Female; Interleukin-6; Neuroprotective Agents; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha

2015
Rosiglitazone attenuates inflammation and CA3 neuronal loss following traumatic brain injury in rats.
    Biochemical and biophysical research communications, 2016, Apr-15, Volume: 472, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Brain Injuries; Cell Survival; Inflammation; Maze Learning; Neurons; Neuroprotective Agents; PPAR gamma; Rats; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha

2016
PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
    Brain research, 2008, Dec-09, Volume: 1244

    Topics: Analysis of Variance; Anilides; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Blotting, Western; Brain Injuries; Cerebral Cortex; Gene Expression; HSP27 Heat-Shock Proteins; Hypoglycemic Agents; In Situ Nick-End Labeling; Injections, Intraperitoneal; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones

2008
Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats.
    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 2008, Volume: 26, Issue:5

    Topics: Animals; Benzamides; Blotting, Western; Brain Injuries; CD40 Antigens; Central Nervous System Diseases; Enzyme-Linked Immunosorbent Assay; Epilepsy; Hippocampus; Immunohistochemistry; Inflammation; Lithium Compounds; Male; Pilocarpine; PPAR gamma; Pyridines; Rats; Rats, Sprague-Dawley; Rosiglitazone; Seizures; Status Epilepticus; Thiazolidinediones; Tumor Necrosis Factor-alpha; Vasodilator Agents

2008
Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents.
    Brain research, 2008, Jun-18, Volume: 1215

    Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries; Disease Models, Animal; Drug Administration Schedule; Inflammation; Intraoperative Complications; Male; Neuroprotective Agents; Neurosurgical Procedures; Peroxidase; Postoperative Complications; PPAR gamma; Random Allocation; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Treatment Outcome

2008